IgG1

IgG1 is the most abundant human IgG subclass, accounting for the majority of circulating IgG and mounting strong responses to protein antigens from viruses and bacteria. Its Fc region combines high-affinity engagement of activating Fc gamma receptors, including CD64 and CD16a, with efficient C1q binding, making IgG1 the strongest complement-fixing and ADCC-mediating subclass. These properties explain why most approved therapeutic monoclonal antibodies, from rituximab to trastuzumab, use an IgG1 Fc, often with glycoengineering or Fc mutation to tune effector function. IgG1 also crosses the placenta efficiently and displays the long serum half-life conferred by FcRn recycling.